Beschreibung:

S0100 FOLLOW UP FORM Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AEB52E43-75AF-43F2-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AEB52E43-75AF-43F2-E034-0003BA12F5E7

Stichworte:

Klinische Studie [Dokumenttyp]

Verlaufsstudien

Leukämie

Versionen (2) ▾

25.05.12
22.01.15

Hochgeladen am:

22. Januar 2015

DOI:

Keine DOI zugewiesen. Für eine Beantragung loggen Sie sich ein.

Lizenz:

Creative Commons BY-NC 3.0 Legacy

Modell Kommentare:

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren

Itemgroup Kommentare für:

Item Kommentare für:

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

FOLLOW UP FORM (S0100)

Details

No Instruction available.

StudyEvent: S0100 FOLLOW UP FORM
1. No Instruction available.

Vital Status

Alive (Alive)

Dead (Dead)

Date of last contact or death

Disease Follow Up Status

Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form? (If Yes, )

Yes

Date of Last Clinical Assessment

Notice Of First Relapse Or Progression

Has the patient developed a first relapse or progression that has not been previously reported? (If Yes)

Yes

Date of Relapse or Progression

Site(s) of Relapse or Progression

Notice Of New Primary

Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported? (If Yes,)

Yes

New Primary Site

Non-protocol Treatment

Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported? (If Yes)

Yes

Date of First Non-Protocol Therapy

Agents

Long Term Toxicity

Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade 3) long term toxicity that has not been previously reported? (If Yes,)

Yes

Toxicities and Grades

Notes

Ccrr Module For S0100 Follow Up Form

SWOG Patient ID

SWOG Study No.

Registration Step

Patient Initials (L, F, M)

Institution/Affiliate

Physician

Group Name

Study No.